期刊文献+

锌指蛋白185对胶质瘤细胞增殖影响的研究 被引量:1

The effect of zinc finger protein 185 on the proliferation of human glioma cells
下载PDF
导出
摘要 目的:探讨锌指蛋白ZNF185在人脑胶质瘤细胞增殖中的作用。方法标本取自2011年1月—2013年12月于唐山市工人医院就诊,经病理确诊为胶质瘤患者的肿瘤组织,以瘤旁组织作对照。提取不同组织总蛋白, Western-blot检测ZNF185的表达。提取瘤旁组织总RNA,反转录扩增ZNF185编码序列并克隆至pEGFPC2质粒,构建ZNF185表达载体。采用Lipofactamine2000将ZNF185表达载体转染人胶质瘤细胞系SF767,以转染pEGFPC2空载体细胞作为对照。采用流式细胞仪检测细胞周期变化;MTT法检测细胞增殖活性。结果与瘤旁组织相比, ZNF185在人脑胶质瘤组织中表达显著降低(P<0.01);转染ZNF185表达载体的胶质瘤细胞与对照细胞相比ZNF185的表达显著增加(P<0.01);过表达ZNF185导致SF767细胞G0~G1期细胞比例显著增加(P<0.05),而S期细胞比例减少(P<0.05)。同时,过表达ZNF185也导致SF767细胞的增殖速度显著降低(P<0.05)。结论ZNF185在人脑胶质瘤细胞中发挥抑制细胞增殖的作用。 Objective To explore the role of zinc finger protein (ZNF)185 in the proliferation of human glioma cells. Methods Human glioma tissues and tumor adjacent tissues were obtained from glioma patients diagnosed pathologically in Tangshan Gongren Hospital from January 2011 to December 2013. Total protein was extracted from different tissues. The ZNF185 expression was detected by Western-blot assay. Total RNA was extracted from tumor adjacent tissues. ZNF 185 cod-ing sequence was obtained by RT-PCR and inserted into pEGFPC2 plasmid to construct the ZNF185 expression vector. Li-pofactamine2000 was used to transfect the ZNF185 expression vector to human glioma cell SF767. pEGFPC2 blank vector transfected SF767 cells were used as control. Changes of cell cycle were analyzed by flow cytometry, and cell proliferation was analyzed by MTT assay. Results The expression of ZNF185 decreased significantly in human glioma tissues compared to that of tumor adjacent tissues(P〈0.01). The over expression of ZNF185 in SF767 resulted in the increased proportion of cell cycle G0-G1phase, but decreased proportion of S phase(P〈0.05). Furthermore, the cell proliferation was significantly inhibited in the ZNF185 over-expressed SF767 cells compared with that of blank vector transfected cells(P〈0.05). Con-clusion ZNF185 plays an inhibitory role in cell proliferation of human brain glioma cells.
作者 陆斌 郑全辉
出处 《天津医药》 CAS 2015年第3期241-244,共4页 Tianjin Medical Journal
基金 河北省自然科学基金面上项目(H2013209019) 唐山市科技局指令性项目(13130290z)
关键词 神经胶质瘤 细胞周期 细胞增殖 锌指 转染 ZNF185 glioma cell cycle cell proliferation zinc fingers transfection ZNF185
  • 相关文献

参考文献3

二级参考文献27

  • 1Benesch M Eder HG Sovinz P Raith J Lackner H Moser A Urban C.Residual or recurrent cerebellar low-grade glioma in children after tumor resection: is re-treatment needed? A single center experience from 1983 to 2003[J].中国神经肿瘤杂志,2006,4(3):204-204. 被引量:15
  • 2原续波,康春生,颜成虎,王虹,谭建,郭艳霜,浦佩玉,张富海,盛京.立体定位注射靶向功能载药纳米粒子治疗恶性脑胶质瘤[J].中国生物医学工程学报,2006,25(6):765-769. 被引量:8
  • 3Heiss NS,Gloeckner G,Bachner D,et al.Genomic structure of a novel LIM domain gene(ZNF185)in Xq28 and comparisons with the ortholo-gous murine transcrip(tJ).Genomics,1997;43(3):329-38.
  • 4Rabbitts TH,Boehm T.LIM domains(J).Nature,1990;346(6283):418.
  • 5Sanchez-Garcia I,Rabbitts T.The LIM domains:a new structural motif found in zinc-finger-like protein(J).Trends Genet,1994;10(9):315-20.
  • 6Zhang JS,Gong A,Young CY.ZNF185,an actin-cytoskeleton-associat-ed growth inhibitory LIM protein in prostate cancer(J).Oncogene,2007;26(1):111-22.
  • 7Vanaja DK,Cheville JC,Iturria SJ,et al.Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression(J).Cancer Res,2003;63(14):3877-82.
  • 8Yamaguchi H,Condeelis J.Regulation of the actin cytoskeleton in cancer cell migration and invasion(J).Biochim Biophys Acta,2007;1773(5):642-52.
  • 9Partap S,Fisher PC.Update on new treatments and developments in childhood barin tumors[J].Curt Opin Pediatr,2007,19(6):670-674.
  • 10黄云燕,夏焱,郭海霞,李文益.5-AZA-CdR联合EGCG对HL-60和K562的影响[J].南方医科大学学报,2008,28(2):204-208. 被引量:1

共引文献15

同被引文献43

  • 1Daly AF, Tichomirowa MA, Beckers A. The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab, 2009, 23:543-554.
  • 2Colao A, Ochoa AS, Auriemma RS, Faggiauo A, Pivonello R, Lombardi G. Pituitary carcinomas. Front Horm Res, 2010, 38:94- 108.
  • 3Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr. Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg, 2011, 114:336- 344.
  • 4Asa SL, Ezzat S. The pathogenesis of pituitary tumors. Annu Rev Pathol, 2009, 4:97-126.
  • 5Tateno T, Asa SL, Zheng L, Mayr T, Ullrich A, Ezzat S. The FGFR4- G388R polymorphism prmnotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis. PLoS Genet, 2011, 7:E1002400.
  • 6Yacqub- Usman K, Richardson A, Duong CV, Clayton RN, Farrell WE. The pituitary tumour epigenome: aberrations and prospects for targeted therapy. Nat Rev Endocrinol, 2012, 8:486- 494.
  • 7Maiter D, Primeau V. 2012 update in the treatment of prolactinomas. Ann Endocrinol (Paris), 2012, 73:90-98.
  • 8Pereira AM. Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia. Curr Opin EndocrinolDiabetes Obes, 2011, 18:264-268.
  • 9Colao A, Grasso LF, Pivonello R, Lombardi G. Therapy of aggressive pituitary tumors. Expert Opin Pharmacother, 2011, 12:1561-1570.
  • 10Kaltsas GA, Grossman AB, Malignant pituitary tumours. Pituitary, 1998, 1:69-81.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部